Clinical Trials Browser

OTHER × Advanced Solid Tumors × liposomal doxorubicin × Clear all

NCT03387917 2024-12-02

TLD-1, a Novel Liposomal Doxorubicin, in Patients With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Advanced Solid Tumors

NCT01148628 2011-09-13

Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Advanced Solid Tumors